Science

Your source for youth perspectives on the environment, science, technology, and engineering.

This material is based upon work supported by the National Science Foundation under Grant No. DRL-1513282 and Grant No. DRL-1614239.

Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.

(FlickrCC/Urbeguayana.com)

Teens Try The Pill That Blocks HIV Infection

The FDA has approved a daily pill called Pre-Exposure Prophalaxis, or PrEP, which can reduce the risk of HIV infection by 86%. It’s the first and only treatment of its kind, but the Centers for Disease Control recommends caution when prescribing PrEP to adolescents. They’re waiting for final results from medical trials on young people being conducted in cities across the country.

Listen Now
Listen Now